Abstract
Background and importanceTofacitinib is an oral JAK inhibitor indicated for the treatment of rheumatoid arthritis, psoriasis arthritis and ulcerative colitis. The efficacy and safety of tofacitinib have been shown in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have